BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 167738)

  • 1. Effect of N-2, 2'-O-dibutyryl cyclic AMP upon the interconvertible forms of cyclic AMP phosphodiesterase from human platelets.
    Pichard AL; Kaplan JC
    Biochem Biophys Res Commun; 1975 May; 64(1):342-6. PubMed ID: 167738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interconvertibility of molecular forms of 3'5' cyclic AMP phosphodiesterase of human platelets].
    Pichard AL; Kaplan JC
    C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(5):673-6. PubMed ID: 170010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics.
    Pichard AL; Cheung WY
    J Biol Chem; 1976 Sep; 251(18):5726-37. PubMed ID: 184086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

  • 5. Separate genetic regulation of cyclic nucleotide phosphodiesterase and its protein activator in cultured mouse fibroblasts.
    Lynch TJ; Tallant EA; Cheung WY
    Biochem Biophys Res Commun; 1975 Apr; 63(4):967-70. PubMed ID: 165822
    [No Abstract]   [Full Text] [Related]  

  • 6. Basal cAMP in Hela cells is protected from phosphodiesterase and does not turn over.
    Hilz H; Kaukel E; Wiegers U; Fuhrmann U
    Biochem Biophys Res Commun; 1975 May; 64(2):519-27. PubMed ID: 167746
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on cyclic adenosine 3' ,5'-monophosphate levels, Adenylate cyclase and phosphodiesterase activities in the dimorphic fungus Mucor rouxii.
    Paveto C; Epstein A; Passeron S
    Arch Biochem Biophys; 1975 Aug; 169(2):449-57. PubMed ID: 170864
    [No Abstract]   [Full Text] [Related]  

  • 8. Marked reduction of cyclic GMP phosphodiesterase activity in virally transformed mouse fibroblasts.
    Lynch TJ; Tallant EA; Cheung WY
    Biochem Biophys Res Commun; 1975 Aug; 65(3):1115-22. PubMed ID: 168890
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclic 3',5'-nucleotide phosphodiesterase in rat skin. II. Biochemical characterization.
    King LE; Solomon SS; Hasimoto K
    J Invest Dermatol; 1975 Jun; 64(6):390-6. PubMed ID: 237964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H; Asano T
    J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distribution of the Ca++-dependent protein activator of cyclic nucleotide phosphodiesterase in invertebrates.
    Waisman D; Stevens FC; Wang JH
    Biochem Biophys Res Commun; 1975 Aug; 65(3):975-82. PubMed ID: 168896
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of thyroxine on the contents of cyclic AMP and on the activity of cyclic AMP phosphodiesterase in hepatocytes of the rat].
    Leoni S; Spagnuolo S
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1874-8. PubMed ID: 182190
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
    Strada SJ; Thompson WJ
    Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of adenosine 3',5'-cyclic monophosphate derivatives on alpha-amylase release, protein kinase and cyclic nucleotide phosphodiesterase activity from rat parotid tissue.
    Butcher FR; Thayer M; Goldman JA
    Biochim Biophys Acta; 1976 Feb; 421(2):289-95. PubMed ID: 175844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP phosphodiesterase activity in Fasciola hepatica (L.) homogenates.
    Simonic T; Sartyorelli P; Locatelli A
    Ann Parasitol Hum Comp; 1975; 50(4):461-8. PubMed ID: 174476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation by insulin of cyclic AMP phosphodiesterase. Role of glutathione-insulin transhydrogenase.
    Phelps BH; Varandani PT
    Biochem Biophys Res Commun; 1977 Mar; 75(2):302-10. PubMed ID: 192234
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclic-AMP phosphodiesterase activity in crown-gall tumor formation.
    Raymond MK; Schmitt G; Galsky AG
    Biochem Biophys Res Commun; 1975 Sep; 66(1):222-6. PubMed ID: 169845
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase].
    Sobolev AS; Orekhov AN; Dhirkov IuIu; Kudriashov IuB
    Dokl Akad Nauk SSSR; 1975 Sep; 224(3):713-6. PubMed ID: 173507
    [No Abstract]   [Full Text] [Related]  

  • 19. Diurnal rhythm in rat pineal cyclic nucleotide phosphodiesterase activity.
    Minneman KP; Iversen LL
    Nature; 1976 Mar; 260(5546):59-61. PubMed ID: 177878
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes of cyclic-AMP and cycic-AMP phosphodiesterase in the progression and regression of experimental atherosclerosis.
    Numano F; Maezawa H
    Ann N Y Acad Sci; 1976; 275():311-20. PubMed ID: 188369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.